Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. [electronic resource]
Producer: 20070508Description: 155-62 p. digitalISSN:- 1532-8414
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Animals
- Antihypertensive Agents -- therapeutic use
- Blood Urea Nitrogen
- Blotting, Western
- Creatinine -- blood
- DNA -- genetics
- Disease Models, Animal
- Heart Failure -- drug therapy
- Immunohistochemistry
- Kidney Failure, Chronic -- complications
- Male
- Matrix Metalloproteinase 2 -- biosynthesis
- Matrix Metalloproteinase 9 -- biosynthesis
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Myocardium -- metabolism
- Nephrectomy -- adverse effects
- Oxidative Stress -- genetics
- Receptor, Angiotensin, Type 1 -- blood
- Signal Transduction -- physiology
- Tetrazoles -- therapeutic use
- Tissue Inhibitor of Metalloproteinase-1 -- genetics
- Transforming Growth Factor beta1 -- biosynthesis
- Treatment Outcome
- Up-Regulation -- drug effects
- Valine -- analogs & derivatives
- Valsartan
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.